Abstract:RNA interference mediated by small interfering RNAs (siRNA) has emerged as a powerful tool to target specific knockdown of gene expression in cell culture. siRNA is now the gold standard technique to study gene function, and expectations for the development of new target-specific drugs are high. In addition to the gene-silencing activity of siRNA, a number of recent studies have pointed to immunological effects of siRNAs, including the induction of proinflammatory cytokines and type I interferon. There is good evidence that gene silencing and immunostimulation are two independent functional characteristics of RNA oligonucleotides. Immunorecognition of RNA depends on certain molecular features such as length, double- versus single-strand configuration, sequence motifs, and nucleoside modifications such as triphosphate residues. RNA-sensing immunoreceptors include three members of the Toll-like receptor (TLR) family (TLR3, TLR7, TLR8) and cytosolic RNA-binding proteins like PKR and the helicases RIG-I and Mda5. Detection of RNA molecules occurs during viral infection and triggers antiviral innate defense mechanisms including the induction of type I interferons (IFN-α, IFN-β) and downregulation of gene expression. Type I interferon induction by synthetic siRNAs requires TLR7 and is sequence dependent, similar to the detection of CpG motifs in DNA by TLR9. Identification of the exact molecular mechanisms of immunorecognition of RNA will allow the development of methods to avoid immunostimulation of siRNA and the design of potent immunostimulatory RNA (isRNA) oligonucleotides, depending on the aim. Furthermore, the combination of both gene-silencing and immunostimulation in one RNA molecule may lead to novel drugs that use both functional activities of RNA as two edges of one sword for effective treatment of viral infection and cancer.

Single-Stranded Hairpin Loop RNAs (loopmeRNAs) Potently Induce Gene Silencing through the RNA Interference Pathway

Application of short hairpin RNAs (shRNAs) to study gene function in mammalian systems

Improved In Vivo Metabolic Stability and Silencing Efficacy of siRNAs with Phosphorothioate Linkage-Free, GalNAc-Conjugated Sense Strands Containing Morpholino-LNA Modifications

Impact of stereopure chimeric backbone chemistries on the potency and durability of gene silencing by RNA interference

SY-9 Stimulation of Innate Immunity by Short Interfering and Micro RNAs

Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms

The therapeutic prospects of N-acetylgalactosamine-siRNA conjugates

Conformation matters: siRNAs with antisense strands with 5′-(E)-vinyl-phosphonate-α-L-LNA elicit stronger RNAi-mediated gene silencing than those with 5′-(E)-vinyl-phosphonate-LNA

A Small Molecule Enhances RNA Interference and Promotes Microrna Processing

Gene knockdown by structure defined single-stem loop small non-coding RNAs with programmable regulatory activities

Circular Sirnas for Reducing Off-Target Effects and Enhancing Long-Term Gene Silencing in Cells and Mice

Ligand conjugate SAR and enhanced delivery in NHP

siRNA, miRNA, and shRNA: in vivo Applications

Short Hairpin RNAs for Strand-Specific Small Interfering RNA Production

A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system

Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems

A Combinatorial Library of Lipid Nanoparticles for RNA Delivery to Leukocytes

GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics.

Enhancing RNA inhibitory activity using clamp-G-modified nucleobases

Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates

RNA Interference-Based Cancer Drugs: The Roadblocks, and the "Delivery" of the Promise